SPOTLIGHT

SAP

SAP is a global software application vendor. SAP is the market leader in enterprise application software, helping companies of all sizes and in all industries run at their best: 77% of the world’s transaction revenue touches an SAP system. Our machine learning, Internet of Things (IoT), and advanced analytics technologies help turn customers’ businesses into intelligent enterprises. Our end-to-end suite of applications and services enables our customers to operate profitably, adapt continuously, and make a differen...

NEWS

featured
Trending

home.aspx

18Sep

Researchers identify two groups of neurons related to Leigh Syndrome
Leigh Syndrome affects one in every 40,000 newborns and is produced by deficits in the mitochondria, which are in charge of providing the energy needed for cells to function correctly. Thus, cells wit...

https://www.news-medical.net/news/20190918/Researchers-identify-two-groups-of-neurons-related-to-Leigh-Syndrome.aspx3534

18Sep

CRISPR’d Stem Cells Could Provide Enduring Therapy for Muscular Dystrophy
In the past several years, we have seen some major advancements in the study of Duchenne muscular dystrophy (DMD), a rare but devastating genetic disorder that causes muscle loss and physical impairme...

https://www.genengnews.com/news/crisprd-stem-cells-could-provide-enduring-therapy-for-muscular-dystrophy/3535

17Sep

Bioengineering organ-specific tissues with high cellular density and embedded vascular channels
Bioengineers study the development of organ-specific tissues in the lab for therapeutic applications. However, the process is highly challenging, since it requires the fabrication and maintenance of d...

https://phys.org/news/2019-09-bioengineering-organ-specific-tissues-high-cellular.html3527

17Sep

Pros and cons of genetic scissors
Crispr technology has greatly facilitated gene editing. Associate Professor Thorsten Müller from Ruhr-Universität Bochum and Dr. Hassan Bukhari from Harvard Medical School discuss its pros a...

https://phys.org/news/2019-09-pros-cons-genetic-scissors.html3528

16Sep

Researchers identify CTLA-4 response marker
The research team headed by Simon Heideger and Hendrick Poeck from Technical University of Munich together with colleagues from Memorial Sloan Kettering Cancer Center, New York, provided new evidence ...

https://european-biotechnology.com/up-to-date/latest-news/news/researchers-identify-ctla-4-response-marker.html3524

16Sep

Researchers find new way to find antibiotics in dirt
Researchers at McMaster have designed a new way to rapidly identify antibiotics hidden in common dirt. Their method, published today in Nature Biotechnology, may help guide drug discovery by allowing ...

https://phys.org/news/2019-09-antibiotics-dirt.html3525

13Sep

Amgen shares hit after analysts expose buried FDA trial halt
Thursday, Amgen posted what appeared to be a fairly innocuous update about its drug Kyprolis and other pipeline assets, but a deeper read turned up a nasty surprise. About midway through its rel...

https://www.fiercebiotech.com/biotech/amgen-shares-hit-after-analysts-expose-buried-fda-trial-halt3521

13Sep

Ritter's microbiome modulator fails lactose intolerance phase 3
A phase 3 trial of Ritter Pharmaceuticals’ lactose intolerance prospect RP-G28 has missed its primary endpoint. The oligosaccharide microbiome modulator was no better than placebo at reducing la...

https://www.fiercebiotech.com/biotech/ritter-s-microbiome-modulator-fails-lactose-intolerance-phase-33522

12Sep

French Biotech to Develop Septic Shock Therapy with €39M Series B
The French company Inotrem has raised €39M to fund an immunotherapy for septic shock, an often deadly condition caused by infections in the bloodstream. Led by the Hong Kong investor Morningside ...

https://labiotech.eu/medical/french-biotech-to-develop-septic-shock-therapy-with-e39m-series-b/3518

EVENTS

Conferences

UPCOMING CONFERENCES
PAST CONFERENCES

WORLD BIOPRESERVATION AND BIOBANKING SUMMIT 2019

September 20-21, 2019

World Biobanking Summit is constructed to draw the attention of academics and industry leaders and this Global two-day Summit will analyze the very best approaches for optimizing the biobanking process from beginning to end. World Biobanking summit has an important role to play in the understanding ...

STEM CELL BIOLOGY

September 17-21, 2019

The meeting will focus on the basic biology of stem cells and the dynamic interactions between stem cells and their microenvironment. Topics will include the mechanisms controlling stem cell proliferation, differentiation, pluripotency and reprogramming. Emerging concepts about the regulation of mul...

TECHNOLOGY TRANSFER FOR BIOLOGICS

September 23-24, 2019

This conference provides attendees with an unequaled opportunity to study and improve fundamental, day-to-day management techniques. Our unmatched speaking faculty helps you to minimize variation between biologic runs at all production scales, maximize biologics quality and predictability, and accel...

7TH EUROBIOTECH CONGRESS

September 23-25, 2019

With great pleasure, we are announcing that the 7th edition of the European Congress of Life Sciences Eurobiotech is going to be organized in Krakow, Poland, from 23 to 25 September 2019. Once again we look forward to welcoming you to the International Exhibition and Convention Centre EXPO Krak&oacu...

THE FUTURE MARTECH CONFERENCE

September 16-18, 2019

The MarTech® Conference is coming to Boston September 16-18, 2019. And even though the event is less than a quarter-mile from our headquarters we didn’t see Conversational Marketing being showcased as a topic at the event. So we had an idea: what if we host an online event with some of our...

PLANT PHYSIOLOGY, PATHOLOGY AND BIOTECHNOLOGY

September 16-17, 2019

Conference Series Ltd conferences, “International Conference on Plant Physiology, Pathology and Biotechnology” during September 16-17, 2019 in Amsterdam, Netherlands aims to bring together leading academic scientists, researchers, specialists and research scholars to exchange and share t...

WORLD BIOSIMILARS AND BIOLOGICS SUMMIT 2019

September 16-17, 2019

Structural Biology 2019 aims to bring together leading academic scientists, researchers, research scholars and entrepreneurs to exchange and share their experiences and research results on all aspects of Structural Molecular Biology and Lexis is delighted to invite all to the upcoming World Biosimil...

MICROBIOLOGY & IMMUNOLOGY 2020

September 16-16, 2019

Microbiology and Immunology cover an array of industries and disciplines, encompassing various research areas including pharmaceuticals, medicine, agriculture, and space. The development of new techniques and the ability to sequence organisms without the need to grow them in the laboratory has opene...

Webinars

live webinar
on demand

SEP 19, 2019

THE HUMAN MICROBIOME: BEYOND THE GUT

The human microbiome has been linked to health and disease. Recent improvements and better accessibility to high-throughput screening have transformed scientists' ability to perform research in this area. This has resulted in a tremendous increase in our knowledge of microbial diversit...

SEP 24, 2019 | 10:00AM

CHARACTERIZATION OF BIOTHERAPEUTICS

Biotherapeutic products are typically characterized by multiple orthogonal methods to evaluate product quality and purity, including assessment of aggregates, variants, and degradation products. For monoclonal antibodies and many other biotherapeutics, analysis of post-translational modifi...

SEP 25, 2019 | 10:00AM

IMPLEMENTATION OF AN AFFORDABLE AND SCALABLE MANUFACTURING STRATEGY FOR GENE THERAPY PRODUCTS

As a start up with multiple clinical programs within an accelerated track we started designing our processes and aimed to build facilities to ensure therapeutic drug products reach patients as quickly as possible. This tends to be the main goal for scientists and patients. Because there ar...

SEP 26, 2019

A SINGLE USE PLATFORM FOR INTENSIFIED VIRAL VECTOR PRODUCTION

This presentation will first describe how vaccine developers can accelerate their timelines and develop highly efficient viral vector processes by using high throughput fully automatic multi-parallel bioreactor testing tools such as ambr®, DoE software and single-use solutions able to ...

SEP 26, 2019

HALLMARKS OF CANCER: FROM BENCH TO BEDSIDE

In this Webinar, Erik Knudsen (Roswell Park Comprehensive Cancer Center), Tony Letai (Harvard Medical School), and Percy Ivy (National Cancer Institute) discuss progress to translate basic scientific findings into clinical therapeutic interventions with drugs targeting, cell cycle, cell de...

SEP 27, 2019

INCREASING THE POSITIVE YIELD OF HEREDITARY CANCER TESTING WITH CONCURRENT DNA AND RNA SEQUENCING

The diagnostic yield of hereditary cancer genetic testing has improved over time as new technologies have been established. Despite these improvements, a substantial proportion of patients undergoing DNA testing for hereditary cancer still either receive inconclusive results or remain with...

PLANTS WITH SUPERPOWERS (GMO) WEBINAR

RESOURCES

MOST READ
ALL RESOURCES

In Accurate, Fast Hydrogen Peroxide Decontamination Validation

whitepaper

The pharmaceutical and medical industry suffers huge pain, high cost and poor results from conventional biological indicators. This new science of using Enzyme Indicators for measuring decontamination...

ANAXOMICS’ METHODOLOGIES - UNDERSTANDING THE COMPLEXITY OF BIOLOGICAL PROCESSE

whitepaper

Biological processes arise from nature’s inherent complexity, and they involve many components connected with positive and negative feedback, sometimes with redundant circuitry, sometimes with d...

Cell Cultivation without Contamination

whitepaper

No other problem in cell culturing is as universal as microbial contamination. In order to avoidit, good sterile techniques and thorough culture handling are essential. Beyond that, the CO2 incubator ...

Application-specific Membrane Prefilters for Highly Efficient Processes in Biopharmaceutical Production

whitepaper

New medicines and diagnostics on the one hand and rising cost pressure as a result, for example, of the launch of generics and biosimilars on the other mean that new, highly efficient methods are requ...

Online Glucose | Lactate measurement in Batch and Fed-batch CHO cultivation

whitepaper

During the cultivation of animal cells the monitoring of nutrients and metabolites has an important role for the controlling strategy of the cell culture. The measurement of glucose and lactate is one...

Process optimization made easy: design of experiments with multi-bioreactor system BIOSTAT® Qplus

whitepaper

Design of experiments (DoE) is one of the most important techniques for systematic planning, execution and statistical evaluation of experiments. Although a DoE investigation is executable in one bior...

Rapid and Precise Biosimilar Candidate Profiling by nanoDSF

whitepaper

The development of biosimilars requires extensive physicochemical characterization of biosimilar candidate molecules which should match the quality profile of the reference molecule (originator). Here...

Getting the Full Picture: Predicting the Aggregation Propensity of mAbs Using Chemical and Thermal Denaturation on a Single, Fully Automated Platform

whitepaper

The presented data demonstrates that chemical denaturation is a feasible approach to predict the colloidal long-term stability of biologicals. Moreover, changes in G in dependence of the protein con...

DocuSign and 21 CFR Part 11

whitepaper

It is the nirvana that Life Sciences organizations have been chasing for the past 30 years. The time is finally now. A digital transformation is taking place in the life sciences industry, from resear...

I agree to the terms of service and privacy policy.

SPOTLIGHT

NEWS

Researchers identify two groups of neurons related to Leigh Syndrome Leigh Syndrome affects one in every 40,000 newborns and is produced by deficits in the mitochondria, which are in charge of providing the energy needed for cells to function correctly. Thus, cells wit...

CRISPR’d Stem Cells Could Provide Enduring Therapy for Muscular Dystrophy In the past several years, we have seen some major advancements in the study of Duchenne muscular dystrophy (DMD), a rare but devastating genetic disorder that causes muscle loss and physical impairme...

Bioengineering organ-specific tissues with high cellular density and embedded vascular channels Bioengineers study the development of organ-specific tissues in the lab for therapeutic applications. However, the process is highly challenging, since it requires the fabrication and maintenance of d...

Pros and cons of genetic scissors Crispr technology has greatly facilitated gene editing. Associate Professor Thorsten Müller from Ruhr-Universität Bochum and Dr. Hassan Bukhari from Harvard Medical School discuss its pros a...

Researchers identify CTLA-4 response marker The research team headed by Simon Heideger and Hendrick Poeck from Technical University of Munich together with colleagues from Memorial Sloan Kettering Cancer Center, New York, provided new evidence ...

Researchers find new way to find antibiotics in dirt Researchers at McMaster have designed a new way to rapidly identify antibiotics hidden in common dirt. Their method, published today in Nature Biotechnology, may help guide drug discovery by allowing ...

Amgen shares hit after analysts expose buried FDA trial halt Thursday, Amgen posted what appeared to be a fairly innocuous update about its drug Kyprolis and other pipeline assets, but a deeper read turned up a nasty surprise. About midway through its rel...

Ritter's microbiome modulator fails lactose intolerance phase 3 A phase 3 trial of Ritter Pharmaceuticals’ lactose intolerance prospect RP-G28 has missed its primary endpoint. The oligosaccharide microbiome modulator was no better than placebo at reducing la...

French Biotech to Develop Septic Shock Therapy with €39M Series B The French company Inotrem has raised €39M to fund an immunotherapy for septic shock, an often deadly condition caused by infections in the bloodstream. Led by the Hong Kong investor Morningside ...

EVENTS

Conferences

Webinars

RESOURCES

Researchers identify two groups of neurons related to Leigh Syndrome
Leigh Syndrome affects one in every 40,000 newborns and is produced by deficits in the mitochondria, which are in charge of providing the energy needed for cells to function correctly. Thus, cells wit...

CRISPR’d Stem Cells Could Provide Enduring Therapy for Muscular Dystrophy
In the past several years, we have seen some major advancements in the study of Duchenne muscular dystrophy (DMD), a rare but devastating genetic disorder that causes muscle loss and physical impairme...

Bioengineering organ-specific tissues with high cellular density and embedded vascular channels
Bioengineers study the development of organ-specific tissues in the lab for therapeutic applications. However, the process is highly challenging, since it requires the fabrication and maintenance of d...

Pros and cons of genetic scissors
Crispr technology has greatly facilitated gene editing. Associate Professor Thorsten Müller from Ruhr-Universität Bochum and Dr. Hassan Bukhari from Harvard Medical School discuss its pros a...

Researchers identify CTLA-4 response marker
The research team headed by Simon Heideger and Hendrick Poeck from Technical University of Munich together with colleagues from Memorial Sloan Kettering Cancer Center, New York, provided new evidence ...

Researchers find new way to find antibiotics in dirt
Researchers at McMaster have designed a new way to rapidly identify antibiotics hidden in common dirt. Their method, published today in Nature Biotechnology, may help guide drug discovery by allowing ...

Amgen shares hit after analysts expose buried FDA trial halt
Thursday, Amgen posted what appeared to be a fairly innocuous update about its drug Kyprolis and other pipeline assets, but a deeper read turned up a nasty surprise. About midway through its rel...

Ritter's microbiome modulator fails lactose intolerance phase 3
A phase 3 trial of Ritter Pharmaceuticals’ lactose intolerance prospect RP-G28 has missed its primary endpoint. The oligosaccharide microbiome modulator was no better than placebo at reducing la...

French Biotech to Develop Septic Shock Therapy with €39M Series B
The French company Inotrem has raised €39M to fund an immunotherapy for septic shock, an often deadly condition caused by infections in the bloodstream. Led by the Hong Kong investor Morningside ...